Medical comms - Press Releases

Date	Title	Company
15-Jul-2020	CHEMEX is supplying PPEs to help health care personnel against COVID-19	CHEMEX
15-Jul-2020	Santhera Closes First Tranche of Financing Transaction	Santhera Pharmaceuticals
15-Jul-2020	NMD Pharma Receives Approval to Start a combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis	NMD Pharma
15-Jul-2020	Macomics, an immuno-oncology company, secures £3.2 million seed funding from Epidarex Capital & the Scottish Investment Bank	Macomics Ltd
15-Jul-2020	Researchers reveal discovery of new cancer drug fadraciclib	Cyclacel Pharmaceuticals, Inc
15-Jul-2020	PharmaLex further strengthens its capabilities in Regulatory Affairs and Pharmacovigilance	PharmaLex
15-Jul-2020	Macomics, an immuno-oncology company, secures £3.2 million seed funding from Epidarex Capital & the Scottish Investment Bank	Macomics Ltd
15-Jul-2020	CARDIOVASCULAR MEDTECH SECTOR TO ENJOY STRONG GROWTH BUT IT NEEDS A BIGGER FOCUS ON DATA AND REAL-WORLD EVIDENCE	Zegami
15-Jul-2020	RCVS news: A day of firsts as RCVS holds unprecedented virtual Annual General Meeting	The Royal College of Veterinary Surgeons
15-Jul-2020	The world’s largest study on the impact of haemophilia on cognition and behaviour in children and young adults reveals benefit of decades of improving care	Novo Nordisk
15-Jul-2020	Lung cancer in non-smokers likely to respond differently to treatment	The Institute of Cancer Research
15-Jul-2020	Freeline presents new Haemophilia B data at the International Society on Thrombosis and Haemostasis (ISTH) 2020 Meeting	Freeline
15-Jul-2020	Sosei Heptares notes publication of Phase III IRIDIUM data in The Lancet Respiratory Medicine showing benefit of Enerzair® Breezhaler® (QVM149) in uncontrolled asthma	Sosei Group Corporation
15-Jul-2020	Long-term safety of radiotherapy in fewer doses for patients with early breast cancer demonstrated in 10-year study	The Institute of Cancer Research
15-Jul-2020	Transgene and Hypertrust Patient Data Care announce successful go-live of the world’s first blockchain solution for clinical trials of personalized healthcare	Transgene and Hypertrust Patient
15-Jul-2020	Sermonix Pharmaceuticals to Collaborate With Eli Lilly and Company in Studying Combination of Lasofoxifene and Lilly’s CDK 4 and 6 Inhibitor, Abemaciclib, in Metastatic Breast Cancer	Sermonix Pharmaceuticals Inc
15-Jul-2020	Allergy Therapeutics announces invalidation of the Birch MATA MPL Phase III primary endpoint results	Allergy Therapeutics
15-Jul-2020	INTELLEGENS AWARDED FUNDING BY INNOVATE UK TO MODEL COVID-19 DATA AND IMPROVE PANDEMIC MANAGEMENT	Intellegens
15-Jul-2020	APEIRON Biologics and MaxCyte Enter into Clinical and Commercial Licensing Agreement for APN401	APEIRON Biologics and MaxCyte
15-Jul-2020	BAME COMMUNITY AND CORONAVIRUS: OXFORD UNIVERSITY SPIN-OUT ZEGAMI OFFERS MEDICAL PROFESSION ITS DATA VISUALISATION SERVICES FOR FREE TO HELP FIND REASONS WHY BAME PEOPLE ARE AT GREATER RISK FROM CORONAVIRUS	Zegami